Javad Mohammadi-Asl

Javad Mohammadi-Asl

Auto-generated profile, based on publicly available information

Javad Mohammadi-Asl

Noor‐Gene Genetic Laboratory Ahvaz Iran

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2010 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
JMJavad Mohammadi-Asl
Javad Mohammadi-Asl
BLBagher Larijani
Bagher Larijani
LFLaura Fischer
Laura Fischer
STSeyed Mohammad Tavangar
Seyed Mohammad Tavangar
VHVahid Haghpanah
Vahid Haghpanah
PMParvin Mehdipour
Parvin Mehdipour

16 November 2008 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
JNJavad Nasrollahzadeh
Javad Nasrollahzadeh
FSFereydoun Siassi
Fereydoun Siassi
MDMahmood Doosti
Mahmood Doosti
MEMohammad Reza Eshraghian
Mohammad Reza Eshraghian
FSFazel Shokri
Fazel Shokri
SKSeyed Morteza Karimian
Seyed Morteza Karimian
Background: Experimental studies indicate that gamma linolenic acid (GLA) and docosahexaenoic acid (DHA) may inhibit glioma cells growth but effects of oral consumption of these fatty acids on brain tumor fatty acid composition have not been determined in vivo. Methods: GLA oil (GLAO; 72% GLA), DHA oil (DHAO; 73% DHA) were fed to adult wistar rats (1 mL/rat/day) starting one week prior to C6 glioma cells implantation and continued for two weeks after implantation. Control group were fed same amount of high linoleic acid safflower oil (74–77% linoleic acid). Fatty acid composition of tumor samples was determined in a set of 8–12 animals in each group and serum fatty acid in 6 animals per each group. Gene expression of tumor fatty acid binding protein 7 (FABP7), epidermal growth factor receptor (EGFR), peroxisome proliferator activated receptor γ (PPAR-γ) and retinoid × receptor-α (RXR-α) were determined in a set of 18 animals per group. Results: DHAO feeding increased EPA of brain tumors and decreased ratio of n-6/n-3 fatty acids. Serum levels of EPA were also increased in DHAO group. A similar trend in serum and tumor levels of DHA were observed in DHAO group but it did not achieve statistical significance. GLAO increased serum concentration of GLA but had no significant effect on tumor GLA or dihomo-gamma linolenic acid (DGLA) concentrations. Gene expression of FABP7 was up-regulated in tumors of DHAO group but no other significant effects were observed on EGFR, PPAR-γ or RXR-α expression, and expression of these genes in tumors of GLAO were not different from SFO group. Conclusion: Dietary supplementation of DHA containing oil could be an effective way to increase levels of long chain n-3 fatty acids in brain tumors and this increase may be mediated partly by up-regulation of FABP7 expression.

9 May 2008 in Journal of Cancer Research and Clinical Oncology
Verified
Journal Article
Closed access
PDF file
PMParvin Mehdipour
Parvin Mehdipour
LHLaleh Habibi
Laleh Habibi
JMJavad Mohammadi-Asl
Javad Mohammadi-Asl
NKNaser Kamalian
Naser Kamalian
MAMasoud Mehr Azin
Masoud Mehr Azin

20 March 2013 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
MKMajid Kheirollahi
Majid Kheirollahi
MMMasoud Mehrazin
Masoud Mehrazin
NKNaser Kamalian
Naser Kamalian
JMJavad Mohammadi-Asl
Javad Mohammadi-Asl
PMParvin Mehdipour
Parvin Mehdipour

1 November 2010 in Nutrition
Verified
Journal Article
Closed access
HPHamideh Pishva
Hamideh Pishva
SMSoltan-Ali Mahboob
Soltan-Ali Mahboob
PMParvin Mehdipour
Parvin Mehdipour
MEMohammad Reza Eshraghian
Mohammad Reza Eshraghian
JMJavad Mohammadi-Asl
Javad Mohammadi-Asl
FKFarzaneh Karimi
Farzaneh Karimi

16 April 2010 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
PMParvin Mehdipour
Parvin Mehdipour
MMMarzieh Mahdavi
Marzieh Mahdavi
JMJavad Mohammadi-Asl
Javad Mohammadi-Asl
MAMorteza Atri
Morteza Atri